Novo preparing for early launch of weight-loss drug Wegovy in India
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
thederrick.com1d
Bessent defiant on tariffs as he rejects a US recession
U.S. Treasury Secretary Scott Bessent on Sunday struck a defiant tone in the face of global financial markets selling off sharply in response to new U.S. tariffs, arguing the duties ...
Trump administration nixes plan to cover anti-obesity drugs through Medicare
Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...
Trump rejects plan for Medicare to cover weight loss drugs
President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...
Senate Overwhelmingly Rejects Sanders’s Resolutions to Halt Trump Administration’s Israel Aid
Sanders hoped to halt the Trump administration’s planned $8.8 billion sale of bombs and other weaponry to Israel as it ...
thederrick.com5d
Once common, now unusual: Conservative candidate publicly quashes shouts that the other side cheated
The conservative-backed loser of Wisconsin's Supreme Court election promptly conceded the race as it was called, angering his ...
Novo Holdings nearly doubles earnings as Wegovy swells coffers
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment ...
MIRA Pharmaceuticals Enrolls First Subjects in Phase 1 Clinical Trial of Ketamir-2 for Neuropathic Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...